This inventor holds 1 USPTO granted patent. Top assignee: Harbor Branch Oceanographic Institute. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovative Contributions of Sarath P Gunaskera
Introduction
Sarath P Gunaskera is a notable inventor based in Vero Beach, Florida. He has made significant contributions to the field of marine biotechnology, particularly through his research on compounds derived from marine sponges. His work has implications for pharmaceutical applications, showcasing the potential of natural products in medicine.
Latest Patents
Gunaskera holds a patent for "Discorhabdin compounds and methods of use." These compounds are derived from marine sponges of the genus Batzella or can be synthesized through various methods. The patent highlights the utility of these compounds as immunomodulatory agents, antitumor agents, and caspase inhibitors. This innovative approach to utilizing marine resources underscores the importance of biodiversity in drug discovery.
Career Highlights
Sarath P Gunaskera is affiliated with the Harbor Branch Oceanographic Institute, where he conducts research that bridges marine science and medicine. His work has not only advanced scientific understanding but also opened new avenues for therapeutic development. With a focus on the practical applications of his research, Gunaskera exemplifies the role of inventors in translating scientific discoveries into real-world solutions.
Collaborations
Throughout his career, Gunaskera has collaborated with esteemed colleagues such as Peter J McCarthy and Shirley A Pomponi. These partnerships have enriched his research and contributed to the advancement of knowledge in marine biotechnology.
Conclusion
In summary, Sarath P Gunaskera's innovative work in the field of marine-derived compounds has significant implications for medicine. His contributions reflect the potential of natural products in developing new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
